Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-04-18

Clinical Trial Update: Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating adherence monitoring for PrEP using dried blood spots; completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: PrEP Adherence Monitoring | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-18